Published in Crit Care Med on March 01, 2000
Does physiotherapy reduce the incidence of postoperative complications in patients following pulmonary resection via thoracotomy? a protocol for a randomised controlled trial. J Cardiothorac Surg (2008) 0.83
Predictors of atelectasis after pulmonary lobectomy. Surg Today (2008) 0.83
Current devices of respiratory physiotherapy. Hippokratia (2008) 0.82
Reaching consensus on the physiotherapeutic management of patients following upper abdominal surgery: a pragmatic approach to interpret equivocal evidence. BMC Med Inform Decis Mak (2012) 0.81
Effects of Incentive Spirometry on Respiratory Motion in Healthy Subjects Using Cine Breathing Magnetic Resonance Imaging. Ann Rehabil Med (2015) 0.75
Evidence regarding patient compliance with incentive spirometry interventions after cardiac, thoracic and abdominal surgeries: A systematic literature review. Can J Respir Ther (2016) 0.75
Bilateral Shoulder Dysfunction Related to the Lung Resection Area After Thoracotomy. Medicine (Baltimore) (2015) 0.75
Physiotherapy for enhanced recovery in thoracic surgery. J Thorac Dis (2016) 0.75
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J (1995) 7.03
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J (2002) 4.01
Six minute walking distance in healthy elderly subjects. Eur Respir J (1999) 3.56
Bronchodilator responsiveness in patients with COPD. Eur Respir J (2008) 3.13
Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med (1996) 3.05
Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J (2006) 2.93
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol (2000) 2.77
Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax (2003) 2.68
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol (2002) 2.60
Regulation of mucociliary clearance in health and disease. Eur Respir J (1999) 2.43
Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg (1992) 2.43
Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology (2001) 2.41
Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.30
Platypnea-orthodeoxia syndrome: a report of two cases. Acta Cardiol (1993) 2.17
Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg (2003) 2.15
Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Eur Respir J (2010) 2.01
Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med (2000) 1.89
Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J (2011) 1.80
Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J (2006) 1.77
Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax (2005) 1.71
Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J (1997) 1.63
Exercise training after lung transplantation improves participation in daily activity: a randomized controlled trial. Am J Transplant (2012) 1.62
Rehabilitation and acute exacerbations. Eur Respir J (2011) 1.53
Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial. Eur Respir J (2009) 1.52
Physiological basis of improvement after lung volume reduction surgery for severe emphysema: where are we? Eur Respir J (1999) 1.51
Composition of the postprandial refluxate in patients with gastroesophageal reflux disease. Am J Gastroenterol (2001) 1.47
Pulmonary sequestration: a comparison between pediatric and adult patients. Eur J Cardiothorac Surg (2001) 1.46
Anastomotic complications after esophagectomy. Dig Surg (2002) 1.41
[Physiological effects of lung reduction surgery: the contribution of an animal model of emphysema]. Rev Mal Respir (2003) 1.39
Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.39
[COPD and bone metabolism: a clinical update]. Rev Mal Respir (2010) 1.37
Sleeve lobectomy for non-small cell lung cancer. Acta Chir Belg (2004) 1.37
Heparan sulfate proteoglycan expression in human lung-cancer cells. Int J Cancer (1997) 1.31
Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J (2003) 1.27
Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial. Eur Respir J (2002) 1.23
Intrauterine pneumonia. An experimental study. Biol Neonate (1973) 1.20
Inspiratory flow rates at different levels of resistance in elderly COPD patients. Eur Respir J (2007) 1.19
Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur Respir J (2002) 1.19
Primary care spirometry. Eur Respir J (2008) 1.18
A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol (2011) 1.17
Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg (1996) 1.16
Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease. J Cardiopulm Rehabil (2000) 1.16
Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction. Hepatogastroenterology (1999) 1.15
Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis. J Thorac Cardiovasc Surg (1994) 1.14
Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J (2008) 1.13
Rostrocaudal gradient of electrical activation in the parasternal intercostal muscles of the dog. J Physiol (1996) 1.13
Validation of two activity monitors in patients with COPD. Thorax (2009) 1.13
The effects of 5-HT on cholinergic contraction in human airways in vitro. Eur Respir J (1999) 1.13
Authors' response to Walker et al. Thorax (2013) 1.09
The European Union conference on chronic respiratory disease: purpose and conclusions. Eur Respir J (2011) 1.08
2010: the year of the lung. Eur Respir J (2011) 1.07
Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma. Clin Pharmacol Ther (1997) 1.06
Corticosteroids decrease mRNA levels of SERCA pumps, whereas they increase sarcolipin mRNA in the rat diaphragm. J Physiol (2000) 1.06
Exercise training in COPD: how to distinguish responders from nonresponders. J Cardiopulm Rehabil (2001) 1.05
A clinical practice guideline for physiotherapists treating patients with chronic obstructive pulmonary disease based on a systematic review of available evidence. Clin Rehabil (2009) 1.05
COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT). Respir Med (2010) 1.05
Effects of mechanical ventilation on diaphragm function and biology. Eur Respir J (2002) 1.04
Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. Eur J Cardiothorac Surg (1999) 1.04
Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest (2007) 1.04
High-frequency diaphragmatic flutter: symptoms and treatment by carbamazepine. Lancet (1992) 1.03
Relation between endoscopic ultrasound findings and outcome of patients with tumors of the esophagus or esophagogastric junction. Gastrointest Endosc (1997) 1.02
Contractile properties of intercostal muscles and their functional significance. J Appl Physiol (1985) (1985) 1.01
Maximal transrespiratory pressures in obstructive lung disease. Bull Eur Physiopathol Respir (1980) 1.01
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg (2000) 1.00
Regional differences in abdominal pressure swings in dogs. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.00
Reversibility of paraneoplastic bilateral diaphragmatic paralysis after nephrectomy for renal cell carcinoma. Ann Oncol (2000) 1.00
Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg (1997) 1.00
Steroid-induced myopathy and its significance to respiratory disease: a known disease rediscovered. Eur Respir J (1992) 0.99
Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience. Ann Oncol (2004) 0.98
Sinonasal pathology in nonallergic asthma and COPD: 'united airway disease' beyond the scope of allergy. Allergy (2007) 0.96
Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius. Am J Respir Crit Care Med (1999) 0.96
Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT®). Respir Med (2013) 0.96
Model of elasticity of the human lung. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.96